Dignitana AB announces CFO will leave the Company

Files for download
Dignitana Release - wkr0006.pdf

Dignitana AB today announces that Karin Almqvist Liwendahl has decided to leave her position as CFO of Dignitana to move on to a senior position in another company. A recruitment process to find a successor has begun and Karin Almqvist Liwendahl will remain with the company during the notice period.

“Karin has provided valuable leadership to the company, and we appreciate her expertise in addressing some of the challenges that come with accelerating growth,” said William Cronin, CEO of Dignitana AB.

For More Information Contact 

Melissa Bourestom, VP Corporate Communications,  melissa.bourestom@dignitana.com  +1 469-518-5031

About Dignitana

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.  Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB +46 8 121 576 90, certifiedadviser@redeye.se. Learn more at www.dignitana.se or www.dignicap.com